Hoth Therapeutics Inc. (HOTH) stock plunged during current market trading. Here’s to know why?

IMTE Stock

Hoth Therapeutics Inc. (NASDAQ: HOTH) stock declines by 8.29% in the current market trading session. Hoth Therapeutics is a clinical-stage biopharmaceutical business focusing on creating next-generation medicines for medical conditions that are currently unmet. Hoth’s pipeline is aimed at raising the standard of living for patients with atopic dermatitis, skin toxicities linked to cancer treatments, […]

That’s why Hoth Therapeutics (HOTH), Saw happy endings of the year 2020

On the final day of 2020, Hoth Therapeutics (HOTH) shares closed above 44% to reach $2.37, and it stayed in green even in the after-hours session. As a biopharmaceutical company, it announced it had signed a production agreement with Tergus Pharma for HT-001, its new cancer treatment drug. This announcement follows the recent news that […]

Here is What you should know about Hoth Therapeutics, Inc. (HOTH) Stock

PBYI Stock

Hoth Therapeutics, Inc. (HOTH) a biotech Stock trading under $3 just went 46% high on massive volume. HOTH reported this morning that it has reached agreement with Tergus Pharma on the production of HT-001 based on GLP and GMP principles.  The HT-001 topical formulation is designed to cure patients with mild to moderate skin disorders […]